Cornel Popovici
Marseille, 13009, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
ESR1 Y537S Detected in a Brain Metastasis but Not in Plasma ctDNA in HR+/HER2-Low Metastatic Breast Cancer: A Case Report.
Journal: Current oncology (Toronto, Ont.)
Published: June 08, 2026
Cancer risks for ATM variant heterozygotes.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 01, 2025
Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer.
Journal: Nature communications
Published: August 15, 2024
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 24, 2022
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
Journal: American journal of human genetics
Published: June 15, 2021
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 14, 2021
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.
Journal: Cancers
Published: June 08, 2021
National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract.
Journal: European journal of medical genetics
Published: May 22, 2020
Bernard-Soulier syndrome: first human case due to a homozygous deletion of GP9 gene.
Journal: British journal of haematology
Published: February 08, 2020
Major Response to Carboplatin in a Patient With Metastatic Triple-Negative Breast Cancer With Somatic Mutation of BRCA1 and Loss of RAD51B.
Journal: JCO precision oncology
Published: December 01, 2019
Last Updated: 09/26/2026